Chest 2001,119(2):344–352.PubMedCrossRef 25. Sullivan SD, Ramsey SD, Lee TA: The economic burden of COPD. Chest 2000,117(2 Suppl):5S-9S.PubMedCrossRef 26. Hunter MH, King DE: COPD: management of acute exacerbations and chronic stable disease. Am Fam Physician 2001,64(4):603–612.PubMed 27. Hurd S: The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 2000,117(2 Suppl):1S-4S.PubMedCrossRef

28. Lafontaine ER, Cope LD, Aebi C, Latimer JL, McCracken GH Jr, Hansen EJ: The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella TPCA-1 manufacturer catarrhalis to human epithelial cells in vitro. J Bacteriol 2000,182(5):1364–1373.PubMedCrossRef 29. Lipski SL, Akimana C, Timpe JM, Wooten RM, Lafontaine ER: The Moraxella catarrhalis autotransporter McaP is a conserved surface protein that mediates

BTK pathway inhibitors adherence to human epithelial cells through its N-terminal passenger domain. Infect Immun 2007,75(1):314–324.PubMedCrossRef 30. Timpe JM, Holm MM, Vanlerberg SL, Basrur V, Lafontaine ER: Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities. Infect Immun 2003,71(8):4341–4350.PubMedCrossRef 31. Holm MM, Vanlerberg SL, Foley IM, Sledjeski DD, Lafontaine ER: The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells. Infect Immun 2004,72(4):1906–1913.PubMedCrossRef 32. Balder R, DMXAA purchase PJ34 HCl Krunkosky

TM, Nguyen CQ, Feezel L, Lafontaine ER: Hag mediates adherence of Moraxella catarrhalis to ciliated human airway cells. Infect Immun 2009,77(10):4597–4608.PubMedCrossRef 33. Bullard B, Lipski SL, Lafontaine ER: Hag directly mediates the adherence of Moraxella catarrhalis to human middle ear cells. Infect Immun 2005,73(8):5127–5136.PubMedCrossRef 34. Balder R, Hassel J, Lipski S, Lafontaine ER: Moraxella catarrhalis strain O35E expresses two filamentous hemagglutinin-like proteins that mediate adherence to human epithelial cells. Infect Immun 2007,75(6):2765–2775.PubMedCrossRef 35. Plamondon P, Luke NR, Campagnari AA: Identification of a novel two-partner secretion locus in Moraxella catarrhalis. Infect Immun 2007,75(6):2929–2936.PubMedCrossRef 36. Luke NR, Jurcisek JA, Bakaletz LO, Campagnari AA: Contribution of Moraxella catarrhalis type IV pili to nasopharyngeal colonization and biofilm formation. Infect Immun 2007,75(12):5559–5564.PubMedCrossRef 37. Peng D, Hu WG, Choudhury BP, Muszynski A, Carlson RW, Gu XX: Role of different moieties from the lipooligosaccharide molecule in biological activities of the Moraxella catarrhalis outer membrane. FEBS J 2007,274(20):5350–5359.PubMedCrossRef 38. Attia AS, Ram S, Rice PA, Hansen EJ: Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun 2006,74(3):1597–1611.PubMedCrossRef 39.